Publication Recurrent Erythema Nodosum Leprosum Associated With Mycobacterium Indicus Pranii Vaccine In A Case Of Leprosy: A Rare paradox. Kothari R, Vashisht D, Pudasaini N, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021;
Publication Addition of Mycobacterium indicus pranii (MIP) vaccine as an immunotherapeutic with standard chemotherapy in borderline leprosy: A double blind study to assess clinical improvement (A preliminary report). Kamal R, Pathak V, Kumari A, et al. The British journal of dermatology. 2016;
Publication Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis by reciprocal regulation of host dual-specificity phosphatases. Parveen S, Bandhyopadhyay S, Das S, et al. International immunology. 2016; 28 (12) : 585-595.
Publication Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis. Saqib M, Khatri R, Singh B, et al. Tuberculosis (Edinburgh, Scotland). 2016;
Publication Preparation, Characterization and in Vivo Antimycobacterial Studies of Panchovillin-Chitosan Nanocomposites. Rwegasila E, Mubofu EB, Nyandoro SS, et al. International journal of molecular sciences. 2016; Download PDF
Publication Cytotoxic and apoptotic effects of heat killed Mycobacterium indicus pranii (MIP) on various human cancer cell lines. Subramaniam M, In L, Kumar A, et al. Scientific reports. 2016; Download PDF
Publication Addition of immunotherapy to chemotherapy in pediatric borderline leprosy: a clinical evaluation Kamal R, M. N, R. D. International Journal of Contemporary Pediatrics. 2016; Download PDF
Publication Mycobacterium indicus pranii (MIP) mediated host protective intracellular mechanisms against tuberculosis infection: Involvement of TLR-4 mediated signaling. Das S, Chowdhury BP, Goswami A, et al. Tuberculosis (Edinburgh, Scotland). 2016;
Publication Generalized granulomatous dermatitis following Mycobacterium w (Mw) immunotherapy in lepromatous leprosy. Khullar G, Narang T, Saikia UN, et al. Dermatologic therapy. 2016;
Publication Making of a highly useful multipurpose vaccine Talwar G, Singh P, Atrey N, et al. Journal of translational science. 2016; 1 (3) : 69-73. Download PDF
Publication The Progress of Therapeutic Vaccination with Regard to Tuberculosis. Cardona P. Frontiers in microbiology. 2016; Download PDF
Publication Molecular analysis of clinical isolates previously diagnosed as Mycobacterium intracellulare reveals incidental findings of "Mycobacterium indicus pranii" genotypes in human lung infection. Kim S, Park HY, Jeong B, et al. BMC infectious diseases. 2015; Download PDF
Publication Priming with DNA Enhances Considerably the Immunogenicity of hCG β-LTB Vaccine. Nand KN, Gupta JC, Panda A, et al. American journal of reproductive immunology (New York, N.Y. : 1989). 2015; 74 (4) : 302-8.
Publication Immunomodulation in host-protective immune response against murine tuberculosis through regulation of the T regulatory cell function. Das S, Halder K, Goswami A, et al. Journal of leukocyte biology. 2015; 98 (5) : 827-36. Download PDF
Publication Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKCα signalling: a potential candidate in melanoma cancer therapy. Halder K, Banerjee S, Ghosh S, et al. Cancer biology & therapy. 2015;
